Lack of relevance of HIF-1a polymorphisms in breast cancer in a portuguese population

Anticancer Research

Volumn 33, Issue 6, 2013, Pages 2549-2556

  Ribeiro, Ana Luísa ^a,b   Gaspar, Jorge F ^c   Pereira, Teresa ^b   Ribeiro, Vera ^a  

^a UNIVERSITY OF ALGARVE   (Portugal)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UNIVERSIDADE NOVA DE LISBOA   (Portugal)

Author keywords

Breast cancer; Hypoxia inducible factor; MCF 7 cells; Polymorphism; Transcriptional activity

Indexed keywords

ARGININE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PROLINE; SERINE; THREONINE; HIF1A PROTEIN, HUMAN;

ADULT; ARTICLE; BREAST ADENOCARCINOMA; BREAST CANCER; CELL TYPE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC TRANSCRIPTION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MUTANT; POLYMERASE CHAIN REACTION; PORTUGAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SITE DIRECTED MUTAGENESIS; WESTERN BLOTTING; WILD TYPE; BREAST TUMOR; CELL STRAIN MCF 7; GENETICS; HYPOXIA-INDUCIBLE FACTOR; MIDDLE AGED; POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTION INITIATION; TRANSCRIPTIONAL ACTIVITY; TUMOR CELL LINE;

BREAST CANCER; HYPOXIA-INDUCIBLE FACTOR; MCF-7 CELLS; POLYMORPHISM; TRANSCRIPTIONAL ACTIVITY;

BREAST NEOPLASMS; CELL LINE, TUMOR; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MIDDLE AGED; MUTAGENESIS, SITE-DIRECTED; POLYMORPHISM, SINGLE NUCLEOTIDE; PORTUGAL; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION;

MLCS; MLOWN;

EID: 84881366858     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
2. Bertout JA, Patel, SA and Simon MC: The impact of O2 availability on human cancer. Nat Rev Cancer 8: 967-975, 2008.
3. Kaelin WG: The von Hippel-Lindau tumour suppressor protein: O2 sensing and cancer. Nat Rev Cancer 8: 865-873, 2008.
4. Majmundar AJ and Simon MC: Hypoxia-Inducible Factors and the Response to hypoxic stress. Mol cell 40: 294-309, 2010.
5. Bos R, Zhong H, Hanrahan CF, Mommers EC, Semenza GL, Pinedo HM, Abeloff MD, Simons JW, van Diest PJ and van der Wall E: Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis. J Natl Cancer Inst 93: 309-314, 2001.
6. Koukourakis MI, Giatromanolaki A, Skarlatos J, Corti L, Blandamura S, Piazza M, Gatter KC and Harris AL: Hypoxia inducible factor (HIF-1α and HIF-2α) expression in early esophageal cancer and response to photodynamic therapy and radiotherapy. Cancer Res 61: 1830-1832, 2001.
7. Zhong H, De Marzo AM, Laughner E, Lim M, Hilton DA, Zagzag D, Buechler P, Isaacs WB, Semenza GL and Simons JW: Overexpression of hypoxia-inducible factor 1α in common human cancers and their metastases. Cancer Res 59: 5830-5835, 1999.
8. Aebersold DM, Burri P, Beer KT, Laissue J, Djonov V, Greiner RH and Semenza GL: Expression of hypoxia-inducible factor-1alpha: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer. Cancer Res 61: 2911-2916, 2001.
9. Beasley NJ, Leek R, Alam M, Turley H, Cox GJ, Gatter K, Millard P, Fuggle S and Harris AL: Hypoxia-inducible factors HIF-1α and HIF-2α in head and neck cancer: relationship to tumor biology and treatment outcome in surgically resected patients. Cancer Res 62: 2493-2497, 2002.
10. Fransen K, Fenech M, Fredrikson M, Dabrosin C and Soderkvist P: Association between ulcerative growth and hypoxia inducible factor-1alpha polymorphisms in colorectal cancer patients. Mol Carcinog 45: 833-840, 2006.
11. Apaydin I, Konac E, Onen HI, Akbaba M, Tekin E and Ekmekci A: Single nucleotide polymorphisms in the hypoxia-inducible factor-1α (HIF-1α) gene in human sporadic breast cancer. Arch Med Res 39: 338-345, 2008.
12. Gu HF, Zheng X, Abu Seman N, Gu T, Botusan IR, Sunkari VG, Lokman EF, Brismar K and Catrina SB: Impact of the Hypoxia-Inducible Factor-1 α (HIF-1α) Pro582Ser polymorphism on diabetes nephropathy. Diabetes Care, 2012.
13. Lee JY, Choi JY, Lee KM, Park SK, Han SH, Noh DY, Ahn SH, Kim DH, Hong YC, Ha E, Yoo KY, Ambrosone CB and Kang D: Rare variant of hypoxia-inducible factor-1α (HIF-1α) and breast cancer risk in Korean women. Clin Chim Acta 389: 167-170, 2008.
14. Ling FC, Khochfar J, Baldus SE, Brabender J, Drebber U, Bollschweiler E, Hoelscher AH and Schneider PM: HIF-1α protein expression is associated with the environmental inflammatory reaction in Barrett's metaplasia. Dis Esophagus 22: 694-699, 2009.
15. Munoz-Guerra MF, Fernandez-Contreras ME, Moreno AL, Martin ID, Herraez B and Gamallo C: Polymorphisms in the hypoxia-inducible factor 1-α and the impact on the prognosis of early stages of oral cancer. Ann Surg Oncol 16: 2351-8, 2009.
16. Naidu R, Har YC and Taib NA: Associations between hypoxiainducible factor-1α (HIF-1α) gene polymorphisms and risk of developing breast cancer. Neoplasma 56: 441-447, 2009.
17. Tanimoto K, Yoshiga K, Eguchi H, Kaneyasu M, Ukon K, Kumazaki T, Oue N, Yasui W, Imai K, Nakachi K, Poellinger L and Nishiyama M: Hypoxia-inducible factor-1α polymorphisms associated with enhanced transactivation capacity, implying clinical significance. Carcinogenesis 24: 1779-1783, 2003.
18. Fu XS, Choi E, Bubley GJ and Balk SP: Identification of hypoxia-inducible factor-1α (HIF-1α) polymorphism as a mutation in prostate cancer that prevents normoxia-induced degradation. Prostate 63: 215-221, 2005.
19. Kim HO, Jo YH, Lee J, Lee SS and Yoon KS: The C1772T genetic polymorphism in human HIF-1α gene associates with expression of HIF-1α protein in breast cancer. Oncol Rep 20: 1181-1187, 2008.
20. Zagouri F, Sergentanis TN, Gazouli M, Tsigginou A, Dimitrakakis C, Papaspyrou I, Eleutherakis-Papaiakovou E, Chrysikos D, Theodoropoulos G, Zografos GC, Antsaklis A, Dimopoulos AM and Papadimitriou CA: HSP90, HSPA8, HIF-1α and HSP70-2 polymorphisms in breast cancer: a case-control study. Mol Biol Rep 39: 10873-10879, 2012.
21. Ribeiro AL, Correia J and Ribeiro V: Ethnic variability of HIF-1α polymorphisms. Cancer Biomark 5: 273-277, 2009.
22. Silva TM, Paulo C, Gomes BC, Azevedo AP, Teixeira V, Pina JE, Rueff J and Gaspar, JF: Breast cancer risk and common single nucleotide polymorphisms in homologous recombination DNA repair pathway genes XRCC2, XRCC3, NBS1 and RAD51. Cancer Epidemiololy 34: 85-92, 2009.
23. Silva MC, Gaspar JF, Duarte I, Faber A and Rueff J: Glutathione S-transferase GSTM1, GSTT1 and GSTP1 polymorphisms and genotoxicity of hydroquinone in cultured human lymphocytes. Environ Mol Mutagen 43: 258-264, 2004.
24. Kallio PJ, Wilson WJ, O'Brien S and Makino YLP: Regulation of the hypoxia-inducible transcription factor 1α by the ubiquitinproteasome pathway. J Biol Chem 274: 6519-6525, 1999.
25. Carrero P, Okamoto K, Coumailleau P, O'Brien S, Tanaka H and Poellinger L: Redox-regulated recruitment of the transcriptional coactivators CREB-binding protein and SRC-1 to hypoxiainducible factor 1α. Mol Cell Biol 20: 402-415, 2000.
26. Putra AC, Tanimoto K, Arifin M and Hiyama K: Hypoxiainducible factor-1α polymorphisms are associated with genetic aberrations in lung cancer. Respirology 16: 796-802, 2011.
27. Chau CH, Permenter MG, Steinberg SM, Retter AS, Dahut WL, Price DK and Figg WD: Polymorphism in the hypoxia-inducible factor 1α gene may confer susceptibility to androgen-independent prostate cancer. Cancer Biol Ther 4: 1222-1225, 2005.
28. Ling TS, Shi RH, Zhang GX, Zhu H, Yu LZ and Ding XF: Common single nucleotide polymorphism of hypoxia-inducible factor-1α and its impact on the clinicopathological features of esophageal squamous cell carcinoma. Chin J Dig Dis 6: 155-158, 2005.
29. Vainrib M, Golan M, Amir S, Dang DT, Dang LH, Bar-Shira A, Orr-Urtreger A, Matzkin H and Mabjeesh NJ: HIF1α C1772T polymorphism leads to HIF-1α mRNA overexpression in prostate cancer patients. Cancer Biol Ther 13: 720-726, 2012.
30. Wang X, Liu Y, Ren H, Yuan Z, Li S, Sheng J, Zhao T, Chen Y, Liu F, Wang F, Huang H and Hao J: Polymorphisms in the hypoxia-inducible factor-1alpha gene confer susceptibility to pancreatic cancer. Cancer Biol Ther 12: 383-387, 2011.
31. Konac E, Onen HI, Metindir J, Alp E, Biri AA and Ekmekci A: An investigation of relationships between hypoxia-inducible factor-1α gene polymorphisms and ovarian, cervical and endometrial cancers. Cancer Detect Prev 31: 102-109, 2007.
32. Kuwai T, Kitadai Y, Tanaka S, Kuroda T, Ochiumi T, Matsumura S, Oue N, Yasui W, Kaneyasu M, Tanimoto K, Nishiyama M and Chayama K: Single nucleotide polymorphism in the hypoxiainducible factor-1α gene in colorectal carcinoma. Oncol Rep 12: 1033-1037, 2004.
33. Lee SJ, Kim JG, Sohn SK, Chae YS, Moon JH, Kang BW, Park JS, Park JY and Choi GS: No association of the hypoxiainducible factor-1α gene polymorphisms with survival in patients with colorectal cancer. Med Oncol, 2011.
34. Li P, Cao Q, Shao PF, Cai HZ, Zhou H, Chen JW, Qin C, Zhang ZD, Ju XB and Yin CJ: Genetic polymorphisms in HIF1α are associated with prostate cancer risk in a Chinese population. Asian J Androl 14: 864-869, 2012.
35. Ollerenshaw M, Page T, Hammonds J and Demaine A: Polymorphisms in the hypoxia inducible factor-1alpha gene (HIF1α) are associated with the renal cell carcinoma phenotype. Cancer Genet Cytogenet 153: 122-126, 2004.
36. Hsiao PC, Chen MK, Su SC, Ueng KC, Chen YC, Hsieh YH, Liu YF, Tsai HT and Yang SF: Hypoxia inducible factor-1alpha gene polymorphism G1790A and its interaction with tobacco and alcohol consumptions increase susceptibility to hepatocellular carcinoma. J Surg Oncol 102: 163-169, 2011.
37. Dales JP, Beaufils N, Silvy M, Picard C, Pauly V, Pradel V, Formisano-Treziny C, Bonnier P, Giusiano S, Charpin C and Gabert J: Hypoxia inducible factor 1α gene (HIF-1α) splice variants: Potential prognostic biomarkers in breast cancer. BMC Med 8: 44, 2012.
38. Mabjeesh N and Amir S: Hypoxia-inducible factor (HIF) in human tumorigenesis. Histol Histopathol 22: 559-572, 2007.
39. Bos R, van Diest PJ, van der Groep P, Greijer AE, Hermsen MA, Heijnen I, Meijer GA, Baak JP, Pinedo HM, van der Wall E and Shvarts A: Protein expression of B-cell lymphoma gene 6 (BCL-6) in invasive breast cancer is associated with cyclin D1 and hypoxia-inducible factor-1α (HIF-1α). Oncogene 22: 8948-8951, 2003.